Advertisement
Advertisement
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
1.61
USD+0.01
+0.94%
Sep 16, 10:24 UTC -4
Open
Connect Biopharma Holdings Limited Ordinary Shares Profile
About
Info & Links
CEO
Barry D. Quart
Headquarters
SAN DIEGO, CA 92130, UNITED STATES
Industry
Sector
Auditor
CBIZ CPAs P.C.
Share holders
1,331
Employees
62
Connect Biopharma Holdings Limited Ordinary Shares Statistics
Valuation Measures
Market Capitalization2
89.99M
Enterprise Value
50.23M
Enterprise Value/EBITDA(ttm)
-2.05
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
1.37
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
25.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
-6718.23%
Return on Equity(ttm)
--
Return on Invested Capital(ttm)
-30.25%
Return on Assets(ttm)
--
Income Statement
Revenue(ttm)
48.00K
Revenue Per Share(ttm)
--
Gross Profit(ttm)
48.00K
EBITDA(ttm)3
-24.53M
Net Income Available to Common(ttm)
-23.17M
Diluted EPS(ttm)
--
Share Statistics
Beta (5Y Monthly)
-0.09
52-Week Change
31.30%
S&P 500 52-Week Change
17.29%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
--
Dividend Yield
0.00%
Float4
43.13M
% Held by Insiders
22.60%
% Held by Institutions
58.72%
Balance Sheet
Total Cash(mrq)
71.77M
Total Cash Per Share(mrq)
--
Total Debt(mrq)
870.00K
Total Debt/Equity(mrq)
1.22%
Current Ratio(mrq)
7.24%
Quick Ratio(mrq)
7.24%
Book Value Per Share(mrq)
1.28
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.41
Free Cash Flow(ytd)
-22.93M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement